[go: up one dir, main page]

UA117416C2 - MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION - Google Patents

MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION

Info

Publication number
UA117416C2
UA117416C2 UAA201702903A UAA201702903A UA117416C2 UA 117416 C2 UA117416 C2 UA 117416C2 UA A201702903 A UAA201702903 A UA A201702903A UA A201702903 A UAA201702903 A UA A201702903A UA 117416 C2 UA117416 C2 UA 117416C2
Authority
UA
Ukraine
Prior art keywords
syrup
medicinal
action
wide spectrum
oral application
Prior art date
Application number
UAA201702903A
Other languages
Ukrainian (uk)
Inventor
Лена Левонівна Давтян
Олена Олексіївна Хомич
Original Assignee
Національна Медична Академія Післядипломної Освіти Імені П.Л. Шупика
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національна Медична Академія Післядипломної Освіти Імені П.Л. Шупика filed Critical Національна Медична Академія Післядипломної Освіти Імені П.Л. Шупика
Priority to UAA201702903A priority Critical patent/UA117416C2/en
Publication of UA117416C2 publication Critical patent/UA117416C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Винахід належить до галузі медицини і стосується лікарського засобу у формі сиропу для орального застосування, що містить (мас. г): ксиліт 20-40,0, фруктозу 30-50,0, агар-агар 0,5-1,5, лимонну кислоту 0,5-1,5, глюкозамін 5,0-7,0, L-карнітин 8,0-12,0, гліцерин 3,0-5,0 та воду - решта.The invention relates to medicine and relates to a medicinal product in the form of a syrup for oral administration containing (wt. G): xylitol 20-40,0, fructose 30-50,0, agar-agar 0,5-1,5, lemon acid 0.5-1.5, glucosamine 5.0-7.0, L-carnitine 8.0-12.0, glycerol 3.0-5.0 and water - the rest.

UAA201702903A 2017-03-27 2017-03-27 MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION UA117416C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201702903A UA117416C2 (en) 2017-03-27 2017-03-27 MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201702903A UA117416C2 (en) 2017-03-27 2017-03-27 MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION

Publications (1)

Publication Number Publication Date
UA117416C2 true UA117416C2 (en) 2018-07-25

Family

ID=63041255

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201702903A UA117416C2 (en) 2017-03-27 2017-03-27 MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION

Country Status (1)

Country Link
UA (1) UA117416C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11185080B2 (en) 2014-04-30 2021-11-30 Matoke Holdings Limited Antimicrobial compositions
US11730168B2 (en) 2017-10-16 2023-08-22 Matoke Holdings Limited Antimicrobial superabsorbent compositions

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11185080B2 (en) 2014-04-30 2021-11-30 Matoke Holdings Limited Antimicrobial compositions
US11311017B2 (en) 2014-04-30 2022-04-26 Matoke Holdings Limited Antimicrobial compositions
US11730168B2 (en) 2017-10-16 2023-08-22 Matoke Holdings Limited Antimicrobial superabsorbent compositions
US12225905B2 (en) 2017-10-16 2025-02-18 Matoke Holdings Limited Antimicrobial superabsorbent compositions

Similar Documents

Publication Publication Date Title
EA202090573A1 (en) COMPOSITIONS OF NIRAPARIBA
MX2018015699A (en) CANNABINOID FORMULATIONS.
HRP20201506T1 (en) Use of cannabidiolic acid in the treatment of epilepsy
WO2015184127A3 (en) Stable cannabinoid formulations
EA201992162A1 (en) COMPOSITIONS BASED ON NIRAPARIB
CO6541583A2 (en) FEXOFENADINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM
CL2019003572A1 (en) Low-dose brimonidine combinations and uses thereof.
CY1123844T1 (en) PHARMACEUTICAL COMPOSITIONS AND USES ADDRESSING LYSOSOMIC STORAGE DISORDERS
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
CY1124893T1 (en) MAROPITANTIS MEDICINAL MIXTURE
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
UA117416C2 (en) MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION
WO2020190900A8 (en) Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof
ITUA20164387A1 (en) Pharmaceutical composition comprising Cetraria islandica Ach., Sodium hyaluronate and a saline solution for the treatment of diseases of the respiratory system.
EA202191014A1 (en) 4-PYRAZINE-2-ILMETHYL-MORPHOLINE DERIVATIVES AND THEIR USE AS A MEDICINAL PRODUCT
TR201909773T4 (en) A composition for the treatment of neuropathies or neuropathic pain.
BR112014026879A2 (en) oral formulation and substrate
CL2022003426A1 (en) Levilimab Aqueous Pharmaceutical Composition and Its Use
DOP2023000043A (en) PHARMACEUTICAL COMBINATIONS OF STATINS AND FIBRATES FOR THE TREATMENT AND PREVENTION OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES
MX2016017001A (en) Multiparticulated biphasic release system with enhanced bioavailability predictive of acematacine.
UA111462C2 (en) Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication
UA97805U (en) MEDICINE FOR SEDATIVE ACTION IN THE FORM OF THE SOFT CAPTURES
EA201200787A1 (en) ANTIOXIDANT MEANS
UA107631C2 (en) PHARMACEUTICAL COMPOSITION OF MEDICINAL PRODUCT OF SEDATIVE AND SPASMOLITIC ACTION IN THE FORM OF SOFT GELATIN Capsules (OPTIONS)
MX2025012194A (en) Oral pharmaceutical com